Cargando…

Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles

High-density lipoproteins (HDLs) are a group of different subpopulations of sialylated particles that have an essential role in the reverse cholesterol transport (RCT) pathway. Importantly, changes in the protein and lipid composition of HDLs may lead to the formation of particles with reduced ather...

Descripción completa

Detalles Bibliográficos
Autores principales: Syed, Shahan, Nissilä, Eija, Ruhanen, Hanna, Fudo, Satoshi, Gaytán, Meztlli O., Sihvo, Sanna P., Lorey, Martina B., Metso, Jari, Öörni, Katariina, King, Samantha J., Oommen, Oommen P., Jauhiainen, Matti, Meri, Seppo, Käkelä, Reijo, Haapasalo, Karita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175417/
https://www.ncbi.nlm.nih.gov/pubmed/34124613
http://dx.doi.org/10.1016/j.isci.2021.102535
_version_ 1783703053092782080
author Syed, Shahan
Nissilä, Eija
Ruhanen, Hanna
Fudo, Satoshi
Gaytán, Meztlli O.
Sihvo, Sanna P.
Lorey, Martina B.
Metso, Jari
Öörni, Katariina
King, Samantha J.
Oommen, Oommen P.
Jauhiainen, Matti
Meri, Seppo
Käkelä, Reijo
Haapasalo, Karita
author_facet Syed, Shahan
Nissilä, Eija
Ruhanen, Hanna
Fudo, Satoshi
Gaytán, Meztlli O.
Sihvo, Sanna P.
Lorey, Martina B.
Metso, Jari
Öörni, Katariina
King, Samantha J.
Oommen, Oommen P.
Jauhiainen, Matti
Meri, Seppo
Käkelä, Reijo
Haapasalo, Karita
author_sort Syed, Shahan
collection PubMed
description High-density lipoproteins (HDLs) are a group of different subpopulations of sialylated particles that have an essential role in the reverse cholesterol transport (RCT) pathway. Importantly, changes in the protein and lipid composition of HDLs may lead to the formation of particles with reduced atheroprotective properties. Here, we show that Streptococcus pneumoniae pneumolysin (PLY) and neuraminidase A (NanA) impair HDL function by causing chemical and structural modifications of HDLs. The proteomic, lipidomic, cellular, and biochemical analysis revealed that PLY and NanA induce significant changes in sialic acid, protein, and lipid compositions of HDL. The modified HDL particles have reduced cholesterol acceptor potential from activated macrophages, elevated levels of malondialdehyde adducts, and show significantly increased complement activating capacity. These results suggest that accumulation of these modified HDL particles in the arterial intima may present a trigger for complement activation, inflammatory response, and thereby promote atherogenic disease progression.
format Online
Article
Text
id pubmed-8175417
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81754172021-06-11 Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles Syed, Shahan Nissilä, Eija Ruhanen, Hanna Fudo, Satoshi Gaytán, Meztlli O. Sihvo, Sanna P. Lorey, Martina B. Metso, Jari Öörni, Katariina King, Samantha J. Oommen, Oommen P. Jauhiainen, Matti Meri, Seppo Käkelä, Reijo Haapasalo, Karita iScience Article High-density lipoproteins (HDLs) are a group of different subpopulations of sialylated particles that have an essential role in the reverse cholesterol transport (RCT) pathway. Importantly, changes in the protein and lipid composition of HDLs may lead to the formation of particles with reduced atheroprotective properties. Here, we show that Streptococcus pneumoniae pneumolysin (PLY) and neuraminidase A (NanA) impair HDL function by causing chemical and structural modifications of HDLs. The proteomic, lipidomic, cellular, and biochemical analysis revealed that PLY and NanA induce significant changes in sialic acid, protein, and lipid compositions of HDL. The modified HDL particles have reduced cholesterol acceptor potential from activated macrophages, elevated levels of malondialdehyde adducts, and show significantly increased complement activating capacity. These results suggest that accumulation of these modified HDL particles in the arterial intima may present a trigger for complement activation, inflammatory response, and thereby promote atherogenic disease progression. Elsevier 2021-05-12 /pmc/articles/PMC8175417/ /pubmed/34124613 http://dx.doi.org/10.1016/j.isci.2021.102535 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Syed, Shahan
Nissilä, Eija
Ruhanen, Hanna
Fudo, Satoshi
Gaytán, Meztlli O.
Sihvo, Sanna P.
Lorey, Martina B.
Metso, Jari
Öörni, Katariina
King, Samantha J.
Oommen, Oommen P.
Jauhiainen, Matti
Meri, Seppo
Käkelä, Reijo
Haapasalo, Karita
Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
title Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
title_full Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
title_fullStr Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
title_full_unstemmed Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
title_short Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
title_sort streptococcus pneumoniae pneumolysin and neuraminidase a convert high-density lipoproteins into pro-atherogenic particles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175417/
https://www.ncbi.nlm.nih.gov/pubmed/34124613
http://dx.doi.org/10.1016/j.isci.2021.102535
work_keys_str_mv AT syedshahan streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT nissilaeija streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT ruhanenhanna streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT fudosatoshi streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT gaytanmeztllio streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT sihvosannap streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT loreymartinab streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT metsojari streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT oornikatariina streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT kingsamanthaj streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT oommenoommenp streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT jauhiainenmatti streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT meriseppo streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT kakelareijo streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles
AT haapasalokarita streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles